After qualifying in medicine at Cambridge and Oxfor Universities and general medical training in London, Dr Chataway specialised in Neurology over an 8 year period with posts in Edinburgh, Cambridge and London. He was awarded a PhD from Cambridge University in genetic epidemiology of multiple sclerosis and took up his post as a consultant Neurologist in 2001 at St Mary’s Hospital (Imperial College Healthcare NHS Trust) and The National Hospital for Neurology and Neurosurgery, Queen Square (University College Foundation NHS Trust, London). He is now full time at the National Hospital, where he is the MS clinical lead. He is interested in clinical trial work involving novel agents and advanced trial design, as well as service delivery. He was the CI of the recently reported MS-STAT trial in secondary progressive MS (Lancet 2014). He is the co-CI of the forthcoming MRC/EME MS-SMART multi-arm trial in SPMS. He sits on the UK MS Society Grant Review Panel for Care and Services Research; UK MS Society Clinical Trials Network Steering Group; National Institute of Clinical Excellence 2014 MS Guideline Development Group.